Table 2. Relationship of GTF2IRD2P1 with the clinicopathological features of BCa patients.
| Features | Total no. n = 30 |
GTF2IRD2P1 expression | p values | |
|---|---|---|---|---|
| Low (n = 15) | High (n = 15) | |||
| Age (years) | 0.372 | |||
| ≤65 | 16 | 8 | 8 | |
| >65 | 14 | 7 | 7 | |
| Gender | 0.999 | |||
| Female | 6 | 2 | 4 | |
| Male | 24 | 13 | 11 | |
| Smoking | 0.999 | |||
| No | 10 | 4 | 6 | |
| Yes | 20 | 11 | 9 | |
| Tumor size (cm) | 0.669 | |||
| ≤3 | 21 | 11 | 10 | |
| >3 | 9 | 4 | 5 | |
| Lymph node metastasis | 0.999 | |||
| No | 28 | 13 | 15 | |
| Yes | 2 | 2 | 0 | |
| Tumor grading | 0.010 | |||
| Low | 9 | 1 | 8 | |
| High | 21 | 14 | 7 | |
Notes:
GTF2IRD2P1 expression was associated with tumor grading (p = 0.01). However, no correlation was found between GTF2IRD2P1 expression and other features, including age, gender, smoking, tumor size, and lymph node metastasis (all p > 0.05).
BCa, bladder cancer.